Setting the Standard for RWE
Aetion is an industry leader because we pioneer best-in-class scientific approaches. Our seminal peer-reviewed publications push the thinking on what constitutes regulatory-grade evidence and enable broad applicability and acceptance.
Setting the Standard for RWE
SPACE
A structured framework for creating a fit-for-purpose study design that can generate valid and transparent RWE
SPIFD
A structured framework for determining which datasets are fit-for-purpose to answer a given research question
SPIFD2
SPIFD2 harmonizes SPACE and SPIFD templates, calls for articulation of the hypothetical target trial and sources of bias that may arise, incorporates STaRT-RWE reference
Cutting-Edge
Aetion is a proud leader and partner of multiple demonstration projects pushing scientific thinking on RWE.
Aetion’s partnership with FDA began in 2018 with the launch of the RCT DUPLICATE project, led by Brigham and Women’s Hospital (BWH) and Harvard Medical School (HMS) aimed at replicating the results of 30 published RCTs, to see whether the use of RWE would have led to the same regulatory decisions, the final results of which were just published in JAMA.